Viatris (VTRS)
$8.68
0.00 (0.00%)
VTRS Stock Quote Delayed 30 Minutes
7 Biotech Stocks to Buy With Plenty of Power in the Pipeline
With biotech stocks back in favor, investors may selectively pick only those with a deep drug pipeline ahead.
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
$8.84
Market Cap
10.36B
PE Ratio
-16.66
EPS
-0.521
Volume (Avg. Vol.)
11.27M
Day's Range
$8.62 - $8.90
52-Week Range
$8.62 - $13.38
Dividend & Yield
$0.48 (5.53%)
VTRS Stock Predictions, Articles, and Viatris News
Novo Nordisk Suing Mylan Over Generic Victoza Drug
News of Novo Nordisk suing Mylan is spreading as the two companies prepare for a legal battle over a generic version of Victoza.
Wednesday’s Vital Data: Pfizer, Advanced Micro Devices and Apple
Options trading was buzzing in Pfizer, Advanced Micro Devices and Apple on Tuesday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Wednesday: Southern Co, CF Industries Holdings and National-Oilwell Varco
The stock charts of Southern Co, CF Industries Holdings and National-Oilwell Varco are at inflection points at the midpoint of the week.
Here’s How Pfizer Stock (and Pharma) Stand to Benefit From Mylan Deal
The new company emerging from the Pfizer-Mylan deal gets former blockbusters like Lipitor and Celebrex, now generics, and the EpiPen business, which has been an object of scandal.
3 Big Stock Charts for Tuesday: Hanesbrands, Tapestry and Travelers Companies
The stock charts of HBI, TRV and TPR have worked their way into pivotal position as the end of July approaches.
Stock Market Today: High-Growth Stocks Get Hammered
While it was a quiet day for the indices, there were a lot of moves under the surfaces to take note of in the stock market today.
Mylan-Pfizer Deal: MYL Stock Soars on Off-Patent Drug Merger
A new Mylan-Pfizer deal that will have the companies taking part in a merger agreement has MYL stock heading higher on Monday.
EpiPen Shortage: Mylan (MYL) Stock Falls on Continued Scarce Supply
It looks like there is no end is sight to the EpiPen shortage and Mylan (MYL) stock is taking a beating Wednesday on the news.
3 Big Stock Charts for Wednesday: Salesforce.com, DISH Network and F5 Networks
The stock charts of DISH, FFIV and CRM stock are headed into hump-day on the verge of major moves. Here's what you can expect.
5 Must-See Stock Charts for Wednesday: O, AGN, BA
Realty Income, Allergan, Boeing, Mylan and the S&P 500 were big movers on Tuesday. You have to see these must-see stock charts.
3 Big Stock Charts for Monday: American Airlines Group, Mylan and Celgene
The stock charts of CELG, AAL and MYL stock are going to start the new trading week out in a clear technical condition.
Mylan Stock May Fall Further After Hitting 52-Week Lows
Mylan stock is getting smashed after its fourth-quarter earnings results and full-year outlook. MYL stock could still go lower, though.
All Signals Are Positive for Buying Abbott Laboratories
Abbott is about to report another quarter to cap 2018's strong annual performance. ABT stock also offers a dividend for income investors.
Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.
5 Top Stock Trades for Wednesday: AMD’s Teaming Up With Amazon?
Earnings set to the tone for Toyota, CVS Health, Eli Lilly and Mylan as our top stock trades. But midterms will set the tone for the week.
